NDC 66658-113 – Kepivance
Palifermin 5.16 mg/1.2mL · Injection, Powder, Lyophilized, For Solution · Intravenous
Product NDC66658-113
Product details
- Brand name
- Kepivance
- Generic name
- Palifermin
- Labeler
- Swedish Orphan Biovitrum AB (publ)
- Dosage form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Marketing category
- BLA · BLA125103
- Marketed since
- August 4, 2023
- Listing expires
- December 31, 2026
- Pharmacologic class
- Mucocutaneous Epithelial Cell Growth Factor
Active ingredients
- Palifermin 5.16 mg/1.2mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 66658-113-03 | 3 VIAL, SINGLE-USE in 1 CARTON (66658-113-03) / 1.2 mL in 1 VIAL, SINGLE-USE (66658-113-01) | Aug 4, 2023 |